Prospectus approved by ASIC and opening of QBiotics Group capital raise
QBiotics Group Limited is pleased to announce that the company prospectus lodged on Friday 26 October 2018 with the Australian Securities and Investments Commission (ASIC) has passed the statutory seven day review period without requisitions or amendments required by ASIC. The final prospectus can be downloaded by going to qbiotics.com/prospectus.
Due to ASIC's review being completed earlier than QBiotics anticipated, the timetable under the prospectus changes as follows: Offer opens: AEST 5pm Monday 5 November 2018 (instead of Friday 16 November 2018 as noted in the prospectus)
As a result of this change to the offer opening date, QBiotics can now accept completed Application Forms. The remainder of the prospectus timetable is unchanged, in particular the Offer still closes at 5pm on Monday 10 December 2018.
Now that the Offer is open, and the final prospectus is available so that all existing and prospective shareholders can be fully informed by reading the prospectus, the Company is pleased to announce that from 5pm Monday 5 November 2018 the trading halt in shares of the Company via the Off Market Trading process ended. This means that the OMT process is once again operational.